Follow
Maria Debiec-Rychter
Maria Debiec-Rychter
Verified email at kuleuven.be
Title
Cited by
Cited by
Year
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)—update of the NCCN clinical practice guidelines
GD Demetri, RS Benjamin, CD Blanke, JY Blay, P Casali, H Choi, ...
Journal of the National Comprehensive Cancer Network 5 (S2), S-1-S-29, 2007
10982007
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours
M Debiec-Rychter, R Sciot, A Le Cesne, M Schlemmer, P Hohenberger, ...
European journal of cancer 42 (8), 1093-1103, 2006
10792006
Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II …
M Debiec-Rychter, H Dumez, I Judson, B Wasag, J Verweij, M Brown, ...
European journal of cancer 40 (5), 689-695, 2004
5832004
Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants
M Debiec-Rychter, J Cools, H Dumez, R Sciot, M Stul, N Mentens, ...
Gastroenterology 128 (2), 270-279, 2005
5802005
Toward minimal residual disease-directed therapy in melanoma
F Rambow, A Rogiers, O Marin-Bejar, S Aibar, J Femel, M Dewaele, ...
Cell 174 (4), 843-855. e19, 2018
5652018
Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225
GA McArthur, GD Demetri, A Van Oosterom, MC Heinrich, ...
Journal of clinical oncology 23 (4), 866-873, 2005
5342005
Clinical management of uterine sarcomas
F Amant, A Coosemans, M Debiec-Rychter, D Timmerman, I Vergote
The lancet oncology 10 (12), 1188-1198, 2009
5192009
PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t (X; 1)(p11. 2; q21)
P Argani, CR Antonescu, J Couturier, JC Fournet, R Sciot, ...
The American journal of surgical pathology 26 (12), 1553-1566, 2002
3812002
Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials
P Rutkowski, M Van Glabbeke, CJ Rankin, W Ruka, BP Rubin, ...
Journal of clinical oncology 28 (10), 1772, 2010
3792010
Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma
MR Tanas, A Sboner, AM Oliveira, MR Erickson-Johnson, J Hespelt, ...
Science translational medicine 3 (98), 98ra82-98ra82, 2011
3612011
Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate
H Prenen, J Cools, N Mentens, C Folens, R Sciot, P Schöffski, ...
Clinical Cancer Research 12 (8), 2622-2627, 2006
3552006
Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor
P Rutkowski, ZI Nowecki, W Michej, M Dębiec-Rychter, A Woźniak, ...
Annals of surgical oncology 14, 2018-2027, 2007
3432007
The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor
CH Lee, A Mariño-Enriquez, W Ou, M Zhu, RH Ali, S Chiang, F Amant, ...
The American journal of surgical pathology 36 (5), 641-653, 2012
3042012
Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients
O Maertens, H Prenen, M Debiec-Rychter, A Wozniak, R Sciot, P Pauwels, ...
Human molecular genetics 15 (6), 1015-1023, 2006
2742006
Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity
M Debiec‐Rychter, B Wasag, M Stul, I De Wever, A Van Oosterom, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2004
2682004
Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene …
A Mohajeri, J Tayebwa, A Collin, J Nilsson, L Magnusson, FV von Steyern, ...
Genes, Chromosomes and Cancer 52 (10), 873-886, 2013
2602013
14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma
CH Lee, WB Ou, A Mariño-Enriquez, M Zhu, M Mayeda, Y Wang, X Guo, ...
Proceedings of the National Academy of Sciences 109 (3), 929-934, 2012
2502012
Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors
E Beert, H Brems, B Daniëls, I De Wever, F Van Calenbergh, ...
Genes, Chromosomes and Cancer 50 (12), 1021-1032, 2011
2442011
Crenolanib inhibits the drug-resistant PDGFRA D842V mutation associated with imatinib-resistant gastrointestinal stromal tumors
MC Heinrich, D Griffith, A McKinley, J Patterson, A Presnell, ...
Clinical cancer research 18 (16), 4375-4384, 2012
2422012
Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST)
A Gupta, S Roy, AJF Lazar, WL Wang, JC McAuliffe, D Reynoso, ...
Proceedings of the National Academy of Sciences 107 (32), 14333-14338, 2010
2372010
The system can't perform the operation now. Try again later.
Articles 1–20